Purdue University physicist David Nolte has developed technology that can detect motion inside tumors to better gauge the reaction to various drug therapies.
In a nutshell, Holographic Tissue Dynamics Spectroscopy allows researchers to peer inside 3D tumor spheroids. The general idea is that monitoring tumor cell motion can help pharmaceuticals better target cancerous tumors.
Among the key points:
"Fluctuation spectroscopy breaks down the changes into different frequencies, and we can tell how a cell's membranes, mitochondria, nucleus and even cell division respond to drugs. We measure the frequency of light fluctuations as a function of time after a drug is applied."
The Purdue Research Foundation has patented the technology and can license it for commercialization.
This post was originally published on Smartplanet.com